Cabot (NYSE:CBT - Get Free Report) will likely be issuing its quarterly earnings data after the market closes on Monday, February 3rd. Analysts expect the company to announce earnings of $1.74 per share and revenue of $997,104.78 billion for the quarter. Cabot has set its FY 2025 guidance at 7.400-7.800 EPS and its FY25 guidance at $7.40-7.80 EPS.Individual interested in participating in the company's earnings conference call can do so using this link.
Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $1.80 EPS for the quarter, missing analysts' consensus estimates of $1.81 by ($0.01). The firm had revenue of $1 billion during the quarter, compared to the consensus estimate of $1.01 billion. Cabot had a net margin of 9.51% and a return on equity of 26.60%. Cabot's quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.65 EPS. On average, analysts expect Cabot to post $8 EPS for the current fiscal year and $8 EPS for the next fiscal year.
Cabot Trading Down 0.3 %
CBT stock traded down $0.26 during midday trading on Monday, hitting $88.06. 466,432 shares of the company's stock were exchanged, compared to its average volume of 340,077. Cabot has a one year low of $70.63 and a one year high of $117.46. The stock's fifty day moving average price is $97.96 and its 200-day moving average price is $102.46. The company has a market cap of $4.79 billion, a PE ratio of 13.06, a price-to-earnings-growth ratio of 0.78 and a beta of 1.21. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.36 and a current ratio of 2.08.
Cabot Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Friday, February 28th will be given a $0.43 dividend. The ex-dividend date of this dividend is Friday, February 28th. This represents a $1.72 annualized dividend and a dividend yield of 1.95%. Cabot's dividend payout ratio is presently 25.52%.
Cabot declared that its Board of Directors has authorized a share buyback program on Tuesday, December 3rd that authorizes the company to repurchase 10,000,000 shares. This repurchase authorization authorizes the specialty chemicals company to purchase shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company's management believes its shares are undervalued.
Insiders Place Their Bets
In other Cabot news, EVP Hobart Kalkstein sold 34,759 shares of Cabot stock in a transaction on Monday, November 11th. The shares were sold at an average price of $115.23, for a total transaction of $4,005,279.57. Following the completion of the transaction, the executive vice president now directly owns 50,627 shares of the company's stock, valued at $5,833,749.21. The trade was a 40.71 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Lisa M. Dumont sold 865 shares of the stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $111.74, for a total transaction of $96,655.10. Following the completion of the transaction, the chief accounting officer now directly owns 9,742 shares in the company, valued at $1,088,571.08. The trade was a 8.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,190 shares of company stock valued at $5,751,534. 3.07% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Several analysts have issued reports on CBT shares. JPMorgan Chase & Co. downgraded Cabot from a "neutral" rating to an "underweight" rating and set a $105.00 price target on the stock. in a research note on Monday, November 11th. Mizuho cut their target price on Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Cabot currently has an average rating of "Hold" and a consensus price target of $102.00.
Read Our Latest Report on Cabot
Cabot Company Profile
(
Get Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Stories
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.